Temporal evolution of diaphragm thickness and diaphragm excursion among subjects hospitalized with COVID-19: A prospective observational study - 06/06/23
, Arun Raja b, Tejas Menon Suri c, Maroof Ahmad Khan d, Saurabh Mittal c, Karan Madan a, Anant Mohan e
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | The diaphragm has abundant ACE2 receptors making it susceptible to SARS-CoV-2. |
• | We performed diaphragm ultrasound in hospitalized non-intubated COVID-19 patients. |
• | We found decline in end-expiratory diaphragm thickness over 5 days of admission. |
• | We found an increase in diaphragm thickening fraction over 5 days of admission. |
Abstract |
Background |
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has an affinity for the angiotensin-converting enzyme 2 (ACE2) receptors, which are present abundantly on the diaphragm. This study aims to describe temporal changes in diaphragmatic thickness and excursion using ultrasonography in subjects with acute COVID-19.
Methods |
This prospective observational study included adults hospitalized with COVID-19 in the past 48 hours. The diaphragm thickness at end-expiration (DTE), diaphragm thickening fraction (DTF), and diaphragm excursion during tidal breathing (DE) and maximal inspiration (DEmax) were measured using ultrasonography daily for 5 days. The changes in DTE, DTF, DE, and Demax from day 1 to day 5 were assessed.
Results |
This study included 64 adults (62.5% male) with a mean (SD) age of 50.2 (17.5) years. A majority (91%) of the participants had mild or moderate illness. The median (IQR) DTE, DTF (%), DE and Demax on day 1 were 2.2 (1.9, 3.0) mm, 21.5% (14.2, 31.0), 19.2 (16.5, 24.0) mm, and 26.7 (22.0, 30.2) mm, respectively. On day 5, there was a significant reduction in the DTE (p=0.002) with a median (IQR) percentage change of -15.7% (-21.0, 0.0). The DTF significantly increased on day 5 with a median (IQR) percentage change of 25.0% (-19.2, 98.4), p=0.03. There was no significant change in DE and Demax from day 1 to day 5, with a median (IQR) percentage change of 3.6% (-5.2, 15) and 0% (-6.7, 5.9), respectively.
Conclusions |
Non-intubated patients with COVID-19 exhibited a temporal decline in diaphragm thickness with increase in thickening fraction over 5 days of hospital admission. Further research is warranted to assess the impact of COVID-19 pneumonia on diaphragmatic function.
Le texte complet de cet article est disponible en PDF.Keywords : Ultrasonography, Diaphragm, Diaphragm atrophy, Diaphragm function, Respiratory muscle, SARS-CoV-2
Abbreviations : ACE2, APACHE, ARDS, DE, DEmax, DT, DTE, DTF, HFNC, LDH, MIP, NIV, PCFS, RT-PCR, SARS-CoV-2, SOFA, USG
Plan
Vol 83
Article 100960- juin 2023 Retour au numéro
Article précédent
- Underreporting of patient-reported outcomes in cystic fibrosis randomized controlled trials using CONSORT-PRO and RoB 2.0
- Ty Moore, Danya Nees, Brooke Hightower, Lydia Brock, Micah Kee, Audrey Wise, Benjamin Heigle, Ryan Ottwell, Micah Hartwell, Matt Vassar
- Endobronchial valves: 1st Multicenter retrospective study on the 2-step approach
- Thomas Egenod, Nicolas Guibert, Yoann Ammar, Romain Kessler, Benedicte Toublanc, Nicolas Favrolt, Amandine Briault, Hervé Dutau, Frederic Wallyn, Samy Lachkar, Laurent Cellerin, Matthieu Dusselier, Jean Michel Vergnon
Bienvenue sur EM-consulte, la référence des professionnels de santé.